ArticleCancers2022

Combination of Whole-Body Baseline CT Radiomics and Clinical Parameters to Predict Response and Survival in a Stage-IV Melanoma Cohort Undergoing Immunotherapy.

Felix Peisen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.